Results 211 to 220 of about 18,936 (261)

2016 FDA drug approvals

Nature Reviews Drug Discovery, 2017
FDA approval count fell last year, despite a steady regulatory filing rate. FDA approval count fell last year, despite a steady regulatory filing rate.
openaire   +2 more sources

2017 FDA drug approvals

Nature Reviews Drug Discovery, 2018
This corrects the article DOI: 10.1038/nrd.2018.4.
openaire   +3 more sources

2009 FDA drug approvals

Nature Reviews Drug Discovery, 2010
In a year in which regulators and drug companies gained familiarity with risk management strategies, the number of new drug approvals was similar to that in 2008.
openaire   +2 more sources

Antilipemic Drugs and the Position of the FDA

1972
The U.S. Food and Drug Administration is charged with the responsibility of assuring safety and efficacy of marketed drugs and safe conditions for clinical investigation of drugs.
openaire   +2 more sources

The FDA and Drug Uses: Reprise

JAMA: The Journal of the American Medical Association, 1985
To the Editor.— The recent editorial by Dr Archer 1 is a useful addition to the literature exploring the nature and significance of official Food and Drug Administration (FDA) drug labeling and the role of such information in drug selection and use by physicians.
openaire   +2 more sources

OxyContin, the FDA, and Drug Control

Virtual Mentor, 2014
The FDA's decision not to approve generic versions of original-formula OxyContin may keep drug costs high for patients with pain, but the benefits of the newer, abuse-resistant formulation outweigh this harm.
openaire   +2 more sources

The FDA and Drug Safety

Archives of Internal Medicine, 2006
The current Food and Drug Administration (FDA) system of regulating drug safety has serious limitations and is in need of changes. The major problems include the following: the design of initial preapproval studies lets uncommon, serious adverse events go undetected; massive underreporting of adverse events to the FDA postmarketing surveillance system ...
Curt D, Furberg, Arthur A, Levin, Peter A, Gross, Robyn S, Shapiro, Brian L, Strom   +4 more
openaire   +2 more sources

2014 FDA drug approvals

Nature Reviews Drug Discovery, 2015
The FDA approved 41 new therapeutics in 2014, but the bumper year fell short of the commercial power of the drugs approved in 2013.
openaire   +2 more sources

The FDA and Drug Marketing Expenditures

JAMA: The Journal of the American Medical Association, 1991
To the Editor.— An article in the November 14, 1990, issue of JAMA , "The Federal Regulation of Prescription Drug Advertising and Promotion," 1 was most informative. There was, however, conspicuous failure to address a key question: does the Food and Drug Administration (FDA) consider how much advertising and promotion add to the escalating cost of ...
openaire   +2 more sources

Bolstering the FDA's Drug-Safety Authority

New England Journal of Medicine, 2007
The Food and Drug Administration Amendments Act was signed into law on September 27. William Schultz discusses the new regulatory power granted to the FDA.
openaire   +2 more sources